Korea’s growth rebounded in 2025, driven by strong semiconductor exports, supporting both economic momentum and equity market ...
Looking to lock in a high-rate CD account this May? Here's where interest rates could be heading in the month.
Adam Parker’s Trivariate Research analyzes stocks from a macro, fundamental, and quantitative perspective.
Application software valuations have declined significantly year-to-date, with the segment now trading at a 40% discount to the broader software group amid concerns about competit ...
Globevisa analyzes how Dominica's 33-year CBI program provides HNWIs with constitutional reliability and economic ...
Q1 2026 earnings call highlights: 21% bookings growth, Astreya acquisition, Project Leap savings, and updated outlook—read now.
Ukraine-Russia war latest: Trump says he ‘thinks’ Putin agreed to ceasefire in call with Russian leader - Trump claimed he ...
Motorola has launched the Razr and Razr+ flip phones, both going on sale May 21 starting at $799 and $1,099 respectively, with pre-orders opening May 14 ...
After finishing approximately USD $850,000 worth of methane measurement work for 849 wells between October 2025 and April 2026, Zefiro is set to realize approximately USD $450,000 in additional ...
S&P 500 futures rose Wednesday night, following the release of quarterly reports from Big Tech bellwethers. Futures tied to ...
The brands that emerge stronger from challenging cycles are those that simplify, focus on fundamentals, and sharpen the ...
Entropy Neurodynamics and LTR Pharma among ASX health companies reporting clinical milestones reached in quarterly results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results